article thumbnail

8 in 8: Biomarker Testing and Neoadjuvant Immunotherapy for Resectable NSCLC

Society of Thoracic Surgeons - Surgeon

Video 8 in 8: Biomarker Testing and Neoadjuvant Immunotherapy for Resectable NSCLC kchalko Thu, 05/23/2024 - 09:56 In this video in the 8 in 8 Series, Dr. Dwight Owen (Ohio State University) discussed advances in biomarker testing and neoadjuvant immunotherapy for resectable non-small cell lung cancer. Duration 7 min.

article thumbnail

5 Most-Cited Takeaways From the 19th Annual Cardiometabolic Health Congress (CMHC) 

Cardiometabolic Health Congress

cardiometabolic health CME/CE conference: the 19th Annual CMHC. He emphasized the evolving landscape of biomarker utility in enhancing the accuracy of HF prediction and the need for targeted interventions based on these biomarkers. Did you miss the live event or want to catch up on sessions you couldn’t attend?

CME 103
article thumbnail

Primary Prevention Takes Center Stage at the 19th Annual Cardiometabolic Health Congress (CMHC)

Cardiometabolic Health Congress

The 19th Annual CMHC was more than just CME/CE medical education—it ignited global collaboration and inspired groundbreaking innovations. Attendees dove into cutting-edge topics, including FDA updates, resistant hypertension, and cardiac biomarkers. “I I am very inspired and rejuvenated at the 19th Annual CMHC.

CME 64
article thumbnail

The Cardiometabolic Event of the Year: What to Expect at the 19th Annual Cardiometabolic Health Congress (CMHC) 

Cardiometabolic Health Congress

The 2 ½ days of nonstop educational programming will deliver fresh, thought-provoking content focused on the interrelatedness of cardiorenal metabolic diseases and their risk factors.